IGF1-LR3 1mg Peptide – High-Purity Research Peptide
IGF1-LR3 1mg Peptide (Insulin-like Growth Factor 1 Long Arg3) is a synthetic analogue of insulin-like growth factor 1 (IGF-1), modified to reduce binding to IGF-binding proteins. This structural modification makes IGF-1 LR3 a subject of research into growth-factor signalling, peptide structure, and receptor interactionsIGF-1 LR3 1mg
These records can help researchers review the reported analytical results and maintain traceability.
Researchers should consult the relevant product specifications and batch documentation when assessing the material for laboratory use.
What Is IGF-1 LR3?
Its structural characteristics make it relevant to laboratory investigations involving IGF-related pathways, growth-factor signalling, and peptide–receptor interactions.
Research findings depend on the experimental model, study design, and analytical methods used. Laboratory research should not be interpreted as proof of clinical effectiveness, safety, or suitability for human use.
IGF-1 LR3 1mg – Product Specifications
| Specification | Details |
|---|---|
| Product name | IGF-1 LR3 1mg |
| Catalogue number | BWP-IGF1-1 |
| CAS number | 946870-92-4 — verify against technical documentation |
| Molecular formula | C₄₀₀H₆₂₅N₁₁₀O₁₁₅S₉ — verify against a reliable reference |
| Molecular weight | 9,117.6 g/mol — verify against a reliable reference |
| Physical form | Lyophilised solid |
| Reported purity | Greater than 99.1% by HPLC, as stated by the supplier |
| Unit size | 1mg |
| Storage | Follow the current product label and validated stability documentation |
Technical note: Confirm the CAS number, molecular formula, and molecular weight against reliable technical references and the supplier’s current records before publishing. Ensure that all identifiers correspond to the exact IGF-1 LR3 variant being sold.
Laboratory Handling and Storage
IGF-1 LR3 is supplied in lyophilised form. Appropriate storage and handling depend on the product’s documented stability, packaging, and intended analytical application.
- Storage conditions: Follow the temperature and environmental requirements specified in the current product documentation.
- Light and moisture protection: Apply the precautions stated by the supplier.
- Sample preparation: Use validated laboratory procedures appropriate to the intended experiment and analytical method.
- Freeze–thaw considerations: Follow product-specific stability guidance when handling prepared samples.
- Batch traceability: Retain the product label, batch details, and associated COA for research records.
Do not assume that a particular solvent, reconstitution method, or post-preparation storage period is suitable without supporting product-specific information. This product is presented for laboratory research purposes, not human or veterinary administration.
Research Applications of IGF-1 LR3
IGF-1 LR3 is relevant to several areas of laboratory investigation:
1. IGF-Related Signalling
Used as a research subject in studies examining insulin-like growth factor pathways and associated cellular signalling mechanisms.
2. Peptide Structure and Binding
Its structural modifications make it relevant to investigations of peptide characteristics and interactions with IGF-binding proteins.
3. Receptor Interaction Research
May be examined in experimental systems studying interactions between growth factors and their associated receptors.
4. Peptide Characterisation
Why Choose IGF-1 LR3 1mg from Bluewell Peptides?
Bluewell Peptides provides research-focused product information to help customers assess peptide specifications and supporting documentation.
- Reported HPLC purity: The product listing states greater than 99.1% purity.
- Defined unit size: Supplied in a listed 1mg format.
- Research-focused information: Product specifications help researchers assess the material before laboratory evaluation.
- Supplier support: Contact Bluewell Peptides for current technical documentation, availability, and shipping details.
HPLC purity alone does not necessarily establish peptide identity or confirm every aspect of product quality.
Frequently Asked Questions
What is IGF-1 LR3 1mg?
IGF-1 LR3 1mg is a synthetic IGF-1 analogue supplied in lyophilised form for laboratory research and educational purposes.
What does LR3 mean?
LR3 refers to structural modifications to the IGF-1 peptide, including an arginine substitution at position 3 and an N-terminal extension. These modifications distinguish it from native IGF-1.
What purity does Bluewell Peptides report?
The supplied product description states greater than 99.1% purity by HPLC.
Is a Certificate of Analysis available?
Bluewell Peptides states that COA documentation is provided for each batch. Check that the document matches the batch supplied and review the reported analytical methods and results.
Follow the storage conditions specified on the current product label and in supporting stability documentation. Do not assume that storage recommendations for another peptide apply to this product. It does not represent the product as approved for human or veterinary use.
Conclusion
IGF-1 LR3 1mg is a modified IGF-1 analogue relevant to laboratory studies of growth-factor signalling, peptide structure, and binding interactions. Its structural differences from native IGF-1 make it a distinct subject for experimental investigation.
Bluewell Peptides lists the product with HPLC-reported purity greater than 99.1% and states that batch-specific COA documentation is available. Researchers should review the supporting records, confirm the scientific identifiers, and follow documented laboratory handling procedures before use.
